TY  - JOUR 
AU  - Benito Sánchez, Rocío
AU  - Lumbreras, Eva
AU  - Abáigar Alvarado, María
AU  - Delgado, Manuel
AU  - Robledo, Cristina
AU  - García, Juan L.
AU  - Rodríguez-Vicente, Ana E.
AU  - Cañizo Fernández-Roldán, María Consuelo del
AU  - Hernández Rivas, Jesús María
AU  - Gutiérrez Gutiérrez, Norma Carmen
PY  - 2012
SN  - 1744-6872
UR  - http://hdl.handle.net/10366/154678
AB  - [EN] Background 
Chronic myeloid leukemia (CML) is a malignant clonal disorder of the hematopoietic system caused by the expression of the BCR/ABL fusion oncogene. It is well known that CML cells are genetically unstable. However, the mechanisms by...
LA  - eng
PB  - Board
KW  - chronic myeloid leukemia
KW  - DNA repair
KW  - gene expression
KW  - imatinib mesylate
KW  - DNA Repair
KW  - Gene Expression
KW  - Chronic Disease
TI  - Imatinib therapy of chronic myeloid leukemia restores the expression levels of key genes for DNA damage and cell-cycle progression
DO  - 10.1097/FPC.0b013e328351f3e9
T2  - Pharmacogenetics and Genomics
VL  - 22
M2  - 381
ER  -